You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B Cell Lymphomas

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphomas, B-cell Lymphomas Trial in Houston (JV-213, Leukapheresis)

Not yet recruiting
  • Lymphomas
  • B-cell Lymphomas
  • Houston, Texas
    The University of Texas M D Anderson Cancer Center
Mar 6, 2023

Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

Not yet recruiting
  • Follicular Lymphoma
  • +3 more
  • Tazemetostat Pill
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Jun 28, 2023

Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma Trial run by the NCI (Rituximab,

Suspended
  • Burkitt Lymphoma
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Refractory Aggressive B-cell Lymphomas, Refractory B-Cell Non-Hodgkin Lymphoma, Aggressive B-cell NHL Trial in Boston

Not yet recruiting
  • Refractory Aggressive B-cell Lymphomas
  • +12 more
  • Boston, Massachusetts
  • +1 more
Oct 13, 2022

CNS Lymphoma, Secondary CNS Lymphoma Trial run by the National Cancer Institute (NCI) (TEDD-R, TEDDI-R, Ibrutinib)

Recruiting
  • Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 14, 2022

Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas Trial (ATG-031)

Not yet recruiting
  • Advanced Solid Tumors
  • B-cell Non-Hodgkin Lymphomas
  • (no location specified)
Aug 31, 2023

DLBCL, High Grade B-Cell Lymphoma Trial in United States (Venetoclax, Rituximab, Etoposide)

Completed
  • Diffuse Large B-Cell Lymphoma
  • High Grade B-Cell Lymphoma
  • Boston, Massachusetts
  • +5 more
Aug 23, 2022

B-Cell Lymphoma Trial in United States (CPI-1205)

Completed
  • B-Cell Lymphoma
  • Lafayette, Indiana
  • +5 more
May 16, 2022

DLBCL - Diffuse Large B Cell Lymphoma Trial in Italy

Recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
    • Bologna, Italy
    • +12 more
    Sep 4, 2023

    TIM-3/Gal-9 Immune Checkpoints in Primary Central Nervous System

    Completed
    • Lymphoma, B-Cell
      • Montpellier, France
        Uh Montpellier
      Nov 12, 2021

      Lymphoma, B-Cell Trial in Philadelphia (CD19 redirected autologous T cells (CTL019 or CTL119 cells))

      Not yet recruiting
      • Lymphoma, B-Cell
      • CD19 redirected autologous T cells (CTL019 or CTL119 cells)
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Mar 18, 2022

      B Cell Lymphoma Trial in Beijing (SHR-A1912)

      Recruiting
      • B Cell Lymphoma
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Apr 15, 2022

      B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

      Not yet recruiting
      • B-cell Non-Hodgkin Lymphoma
      • +4 more
      • (no location specified)
      Dec 7, 2022

      Lymphoma, Large B-Cell, Diffuse, Fatigue Trial in Columbus (Fatigue Reduction Diet)

      Completed
      • Lymphoma, Large B-Cell, Diffuse
      • Fatigue
      • Fatigue Reduction Diet
      • Columbus, Ohio
        The Ohio State University
      Apr 26, 2022

      Aggressive Non-Hodgkin Lymphoma, CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma Trial in Rochester (Laboratory Biomarker

      Suspended
      • Recurrent Aggressive Non-Hodgkin Lymphoma
      • +5 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 12, 2023

      B-Cell Non-Hodgkin Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma Trial in Palo Alto (biological, other,

      Active, not recruiting
      • B-Cell Non-Hodgkin Lymphoma
      • +7 more
      • Anti-OX40 Antibody BMS 986178
      • +3 more
      • Palo Alto, California
        Stanford University, School of Medicine
      May 3, 2022

      EBV-associated Lymphomas Trial ((Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell

      Not yet recruiting
      • EBV-associated Lymphomas
      • (Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell line lysate
      • (no location specified)
      May 31, 2023

      Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

      Recruiting
      • Diffuse Large Cell Lymphoma
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      CD20+, B-cell Lymphomas, Mantle Cell Lymphoma, Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) Trial in Baltimore

      Completed
      Has Results
      • CD20+, B-cell Lymphomas
      • +5 more
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Oct 4, 2021

      Lymphoma, B-Cell, Lymphoma, T-Cell Trial in Nashville (STP938)

      Recruiting
      • Lymphoma, B-Cell
      • Lymphoma, T-Cell
      • Nashville, Tennessee
        Tennessee Oncology
      Aug 3, 2022

      Hodgkin Lymphoma, DLBCL Trial run by the NCI (campath, Rituximab, EPOCH)

      Completed
      Has Results
      • Hodgkin Lymphoma
      • Diffuse Large B-Cell Lymphoma
      • Campath
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Sep 11, 2022

      Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Huntsville, Bethesda (Ublituximab,

      Terminated
      • Non-Hodgkins Lymphoma
      • +6 more
      • Huntsville, Alabama
      • +1 more
      May 5, 2022

      Advanced Solid Tumor, Metastatic Solid Tumor, Mature B-cell Non-Hodgkin Lymphoma Trial in China (ATG-101)

      Recruiting
      • Advanced Solid Tumor
      • +2 more
      • Jinan, China
      • +3 more
      Aug 3, 2022

      Aggressive Non-Hodgkin Lymphoma Trial in Italy (Prednisone, Vinorelbine, Etoposide)

      Completed
      • Aggressive Non-Hodgkin Lymphoma
      • Brescia, Italy
      • +9 more
      Dec 17, 2021